Elute
2011
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Early Stage VC
LATEST DEAL TYPE
$1.64M
LATEST DEAL AMOUNT
2
INVESTORS
Description
Developer of polymer-controlled drug delivery devices intended to help in prevention of surgical bone infections. The company's devices provide drug coatings for bone grafts and are used for prevention and treatment of orthopedic and other surgical bone infections, enabling physicians to treat their patients in an enhanced way.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Drug Delivery
Primary Office
- 417 Wakara Way
- Suite 3510
- Salt Lake City, UT 84106
- United States
+1 (801) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Elute’s full profile, request a free trial.
Elute Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 31-Mar-2016 | $1.64M | 00.000 | Completed | Generating Revenue |
Elute Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| BoomStartup | Accelerator/Incubator | 000 0000 | 000000 0 | |||
| UpStart Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
Elute Executive Team (6)
2 Former Executives
You’re viewing 4 of 6 executives. Get the full list »Elute Board Members (8)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Ashok Khandkar Ph.D | Elute | Chief Executive Officer, President & Board Member | 000 0000 | |
| Cheryl Blanchard Ph.D | Self | Board Member | 000 0000 | |
| David Grainger Ph.D | Elute | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 | |
| Dennis Farrar JD | Self | Executive Chairman | 000 0000 | |
| Jon Serbousek | Self | Board Member | 000 0000 |
1 Former Board Member
You’re viewing 5 of 8 board members. Get the full list »